GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (FRA:NXE0) » Definitions » Float Percentage Of Total Shares Outstanding

Seelos Therapeutics (FRA:NXE0) Float Percentage Of Total Shares Outstanding : 98.60% (As of Jun. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Seelos Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Seelos Therapeutics's float shares is 2.57 Mil. Seelos Therapeutics's total shares outstanding is 2.61 Mil. Seelos Therapeutics's float percentage of total shares outstanding is 98.60%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Seelos Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Seelos Therapeutics's Institutional Ownership is 7.40%.

Seelos Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Seelos Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.57/2.61
=98.60%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seelos Therapeutics (FRA:NXE0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (FRA:NXE0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
FNCH APVO XCUR TSOI REVB CYCC BTAX CPMV AXIM ELOX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
SEEL:USA
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Website
https://www.seelostherapeutics.com
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.

Seelos Therapeutics (FRA:NXE0) Headlines

No Headlines